Amanda Michele Stahnke, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6010 Bond Ave, Centreville, IL 62207 Phone: 618-337-8153 |
News Archive
MedImmune today announced that the U.S. Food and Drug Administration's Antiviral Drugs Advisory Committee has voted 14 to 3 to recommend that motavizumab should not be licensed for marketing regarding the prevention of serious respiratory syncytial virus disease in high-risk infants.
The 11th annual research conference of the Ontario HIV Treatment Network will examine the factors that increase risk for individuals and communities most affected by HIV, as well as interventions that may improve the lives of people living with HIV and prevent the spread of the virus.
People with Chronic Obstructive Pulmonary Disease need more support when understanding and acting on new chest symptoms, a study in the journal Psycho-Oncology reports.
Studies conducted at the Comprehensive Cancer Center at MedUni Vienna and Vienna General Hospital show that the drugs ibrutinib and idelalisib used in the targeted treatment of chronic lymphatic leukaemia can significantly prolong the survival time of high-risk patients.
› Verified 7 days ago